Clinical reference
Gastric acid reducer · Histamine H2-receptor antagonist · Neonatology, Pediatrics, Gastroenterology
H2-receptor antagonist for prevention and treatment of stress ulcers and GI hemorrhage. PO 2 mg/kg q8h; IV term 1.5 mg/kg q8h, preterm 0.5 mg/kg q12h; continuous IV 0.03–0.0625 mg/kg/hr; ECMO 2 mg/kg q12–24h. US prescription and OTC ranitidine discontinued 4/1/2020 (NDMA). Do not use for crying/irritability or regurgitation in healthy term infants; risks…